The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development
Open accessAbstract
TDP-43 is a DNA/RNA-binding protein implicated in multiple steps of transcriptional and post-transcriptional regulation of gene expression. Alteration of this multifunctional protein is associated with a number of neurodegenerative diseases including amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitin positive inclusions. Whereas a pathological link to neurodegenerative disorders has been established, the cellular and physiological functions of TDP-43 remain unknown. In this study, we show that TDP-43 is a nuclear protein with persistent high-level expression during embryonic development and with progressively decreased protein levels during postnatal development. In mice where the TDP-43 gene (Tardbp) was disrupted using a gene trap that carries a beta-galactosidase marker gene, heterozygous (Tardbp(+/-)) mice are fertile and healthy, but intercrosses of Tardbp(+/-) mice yielded no viable homozygotic null (Tardbp(-/-)) mice. Indeed, Tardbp(-/-) embryos die between 3.5 and 8.5 days of development. Tardbp(-/-) blastocysts grown in cell culture display abnormal expansion of their inner cell mass. The pattern of beta-galactosidase staining at E9.5 Tardbp(+/-) embryos is predominantly restricted to the neuroepithelium and remains prominent in neural progenitors at E10.5-12.5. TDP-43 is detected in spinal cord progenitors and in differentiated motor neurons as well as in the dorsal root ganglia at E12.5. Beta-galactosidase staining of tissues from adult Tardbp(+/-) mice shows widespread expression of TDP-43, including prominent levels in various regions of the central nervous system afflicted in neurodegenerative disorders. These results indicate that TDP-43 is developmentally regulated and indispensible for early embryonic development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALS-like phenotypes are seen in mice with partial depletion of TDP43 by RNA interference, or with targeted deletion of Tdp43 in motor neurons”
From The neurogenetics of alternative splicing (2016) · cites this paper as [164]
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedUbiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
hnRNP PROTEINS AND THE BIOGENESIS OF mRNA
Dreyfuss, G., Matunis, M. J., Piñol-Roma, S., & Burd, C. G. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.001445 · Cited by 1,558
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Ou, S.-H. I., Wu, F. K., Harrich, D., Garcı́a-Martı́nez, L. F., & Gaynor, R. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3584-3596.1995 · Cited by 762
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M., & Baloh, R. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908767106 · Cited by 706
Nuclear factor TDP‐43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping
Buratti, E., Dörk, T., Zuccato, E., Pagani, F., Romano, M., & Baralle, F. E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1774 · Cited by 633
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Zhang, Y., Xu, Y.-F., Cook, C. N., Gendron, T. F., Roettges, P. S., Link, C. D., Lin, W.-L., Tong, J., Castanedes‐Casey, M., Ash, P. E. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900688106 · Cited by 614
Rethinking ALS: The FUS about TDP-43
Lagier‐Tourenne, C., & Cleveland, D. W. (2009) · Cell · doi:10.1016/j.cell.2009.03.006 · Cited by 596
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
Buratti, E. (2007) · Frontiers in bioscience · doi:10.2741/2727 · Cited by 493
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 371
Ambegaokar, S. S., Roy, B., & Jackson, G. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.026 · Cited by 80
Biology and Pathobiology of TDP-43 and Emergent Therapeutic StrategiesPreprint
Guo, L. E., & Shorter, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024554 · Cited by 85
LaClair, K. D., Donde, A., Ling, J. P., Jeong, Y. H., Chhabra, R., Martin, L. J., & Wong, P. C. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1637-y · Cited by 76
RNA-binding proteins in neurological diseases
Zhou, H.-L., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J. Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4647-9 · Cited by 82
From molecule to molecule and cell to cell: Prion-like mechanisms in amyotrophic lateral sclerosis
Grad, L. I., Fernando, S. M., & Cashman, N. R. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.009 · Cited by 80
Neuronal Function and Dysfunction of Drosophila dTDP
Lin, M.-J., Cheng, C.-W., & Shen, C. ‐. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020371 · Cited by 77
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
Ito, D., & Suzuki, N. (2011) · Neurology · doi:10.1212/wnl.0b013e3182343365 · Cited by 78
Appocher, C., Mohagheghi, F., Cappelli, S., Stuani, C., Romano, M., Feiguin, F. M., & Buratti, E. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx477 · Cited by 76
The role of altered protein acetylation in neurodegenerative disease
Kabir, F., Atkinson, R., Cook, A. L., Phipps, A. J., & King, A. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1025473 · Cited by 75
TDP-43 Is a Transcriptional Repressor
Lalmansingh, A. S., Urekar, C., & Reddi, P. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.166587 · Cited by 74
Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis
Ishihara, T., Ariizumi, Y., Shiga, A., Kato, T., Tan, C., Sato, T., Miki, Y., Yokoo, M., Fujino, T., Koyama, A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt262 · Cited by 74
TDP-43 dysfunction results in R-loop accumulation and DNA replication defects
Wood, M. D., Quinet, A., Lin, Y., Davis, A. A., Pasero, P., Ayala, Y. M., & Vindigni, A. (2020) · Journal of Cell Science · doi:10.1242/jcs.244129 · Cited by 72
TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Bright, F., Chan, G., van Hummel, A., Ittner, L. M., & Ke, Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157781 · Cited by 71
TDP‐1, the Caenorhabditis elegans ortholog of TDP‐43, limits the accumulation of double‐stranded RNA
Saldi, T. K., Ash, P. E., Wilson, G., Gonzales, P., Garrido‐Lecca, A., Roberts, C. M., Dostal, V., Gendron, T. F., Stein, L. D., Blumenthal, T., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488740 · Cited by 71
Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span
Zhāng, T., Hwang, H., Hao, H., Talbot, C. C., & Wang, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311977 · Cited by 75
Tanji, K., Zhang, H., Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23081 · Cited by 72
Linking pathways in the developing and aging brain with neurodegeneration
Kovács, G. G., Adle‐Biassette, H., Milenković, I., Cipriani, S., van Scheppingen, J., & Aronica, E. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.045 · Cited by 69
Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis
Roczniak-Ferguson, A., & Ferguson, S. M. (2019) · Life Science Alliance · doi:10.26508/lsa.201900358 · Cited by 75
TDP‐43 and FUS/TLS: cellular functions and implications for neurodegeneration
Fiesel, F. C., & Kahle, P. J. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08258.x · Cited by 69
Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis
Ly, C. V., & Miller, T. M. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000594 · Cited by 70
Scialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69
TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43
Gendron, T. F., Rademakers, R., & Petrucelli, L. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129036 · Cited by 70
TDP-43: A DNA and RNA binding protein with roles in neurodegenerative diseases
Warraich, S. T., Yang, S., Nicholson, G. A., & Blair, I. P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.016 · Cited by 70
Broeck, L. V., Naval-Sánchez, M., Adachi, Y., Diaper, D. C., Dourlen, P., Chapuis, J., Kleinberger, G., Gistelinck, M., Broeckhoven, C. V., Lambert, J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.014 · Cited by 67
Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction
Cannon, A. D., Yang, B., Knight, J. A., Farnham, I. M., Zhang, Y., Wuertzer, C. A., D’Alton, S., Lin, W.-L., Castanedes‐Casey, M., Rousseau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0979-3 · Cited by 68
RNA‐binding proteins in neurodegenerative disease: TDP‐43 and beyond
Hanson, K. A., Kim, S. H., & Tibbetts, R. S. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.111 · Cited by 68
Gendron, T. F., & Petrucelli, L. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9610-7 · Cited by 66
TDP43 and RNA instability in amyotrophic lateral sclerosis
Weskamp, K., & Barmada, S. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.015 · Cited by 68
Nag, S., & Schneider, J. A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00846-7 · Cited by 69
Barmada, S. J., & Finkbeiner, S. M. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.4.251 · Cited by 63
Fishing for causes and cures of motor neuron disorders
Patten, S. A., Armstrong, G. A. B., Lissouba, A., Kabashi, E., Parker, J. A., & Drapeau, P. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015719 · Cited by 70
TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons
Vogt, M. A., Ehsaei, Z., Knuckles, P., Higginbottom, A., Helmbrecht, M. S., Kunath, T., Eggan, K. C., Williams, L. A., Shaw, P. J., Wurst, W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26397-2 · Cited by 61
ALS pathogenesis: Recent insights from genetics and mouse models
Swarup, V., & Julien, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.006 · Cited by 65
Li, W., Reeb, A. N., Lin, B., Subramanian, P., Fey, E. E., Knoverek, C. R., French, R. L., Bigio, E. H., & Ayala, Y. M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753913 · Cited by 62
Gelon, P. A., Dutchak, P. A., & Sephton, C. F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1000183 · Cited by 64
Self-citationWang, D. B., Dayton, R. D., Henning, P. P., Cain, C. D., Zhao, L. R., Schrott, L. M., Orchard, E. A., Knight, D. S., & Klein, R. L. (2010) · Molecular Therapy · doi:10.1038/mt.2010.191 · Cited by 60
TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1
He, F., Krans, A., Freibaum, B. D., Taylor, J. P., & Todd, P. K. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu216 · Cited by 62
Brain-trait-associated variants impact cell-type-specific gene regulation during neurogenesis
Aygün, N., Elwell, A. L., Liang, D., Lafferty, M. J., Cheek, K. E., Courtney, K. P., Mory, J. T., Hadden-Ford, E., Krupa, O., de la Torre-Ubieta, L., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.07.011 · Cited by 57
Progranulin and TDP-43: Mechanistic Links and Future Directions
Kumar‐Singh, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9625-0 · Cited by 56
RNA‐binding proteins implicated in neurodegenerative diseases
Cookson, M. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1397 · Cited by 58
Prasad, A., Raju, G., Sivalingam, V., Girdhar, A., Verma, M., Vats, K., Taneja, V., Prabusankar, G., & Patel, B. K. (2016) · Scientific Reports · doi:10.1038/srep39490 · Cited by 56
Yang, C., Qiao, T., Yu, J. H., Wang, H., Guo, Y., Salameh, J. S., Metterville, J., Parsi, S., Yusuf, I. O., Brown, R. H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0255710 · Cited by 55
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Hruška-Plocháň, M., Wiersma, V. I., Betz, K. M., Mallona, I., Ronchi, S., Maniecka, Z., Hock, E., Tantardini, E., Laferrière, F., Sahadevan, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07042-7 · Cited by 73
Amyotrophic lateral sclerosis: an update on recent genetic insights
Iguchi, Y., Katsuno, M., Ikenaka, K., Ishigaki, S., & Sobue, G. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7112-y · Cited by 56
Making sense of antisense oligonucleotides: A narrative review
Goyal, N., & Narayanaswami, P. (2017) · Muscle & Nerve · doi:10.1002/mus.26001 · Cited by 55
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights
Rummens, J., & Cruz, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00851-y · Cited by 62
Medina, D. X., Orr, M. E., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.006 · Cited by 50
Sustained Expression of TDP-43 and FUS in Motor Neurons in Rodent's Lifetime
Huang, C., Xia, P. Y., & Zhou, H. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.396 · Cited by 51
Vue, T. Y., Kim, E. J., Parras, C. M., Guillemot, F., & Johnson, J. E. B. (2014) · Development · doi:10.1242/dev.105270 · Cited by 49
Nishimura, A. L., Shum, C., Scotter, E. L., Abdelgany, A., Sardone, V., Wright, J. M., Lee, Y., Chen, H.-J., Bilican, B., Carrasco, M. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091269 · Cited by 52
Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications
Liu, Y.-C., Chiang, P., & Tsai, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020079 · Cited by 52
Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43
Heo, D., Ling, J. P., Molina-Castro, G. C., Langseth, A. J., Waisman, A., Nave, K., Möbius, W., Wong, P. C., & Bergles, D. E. (2022) · eLife · doi:10.7554/elife.75230 · Cited by 49
Altered astrocytic expression of TDP-43 does not influence motor neuron survival
Haidet-Phillips, A. M., Gross, S. K., Williams, T. L., Tuteja, A., Sherman, A., Ko, M., Jeong, Y. H., Wong, P. C., & Maragakis, N. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.004 · Cited by 51
TDP-43 drives synaptic and cognitive deterioration following traumatic brain injury
Gao, F., Hu, M., Zhang, J., Hashem, J., & Chen, C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02449-w · Cited by 49
TDP-43 PrionsPreprint
Nonaka, T., & Hasegawa, M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024463 · Cited by 50
Romano, M., Buratti, E., Romano, G., Klima, R., Belluz, L. D. B., Stuani, C., Baralle, F. E., & Feiguin, F. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548859 · Cited by 47
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
Barmada, S. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0340-3 · Cited by 52
FUS contributes to mTOR-dependent inhibition of translation
Sévigny, M., Bourdeau‐Julien, I., Venkatasubramani, J. P., Hui, J. B., Dutchak, P. A., & Sephton, C. F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013801 · Cited by 49
Self-citationTardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish
Hewamadduma, C., Grierson, A. J., Ma, T. P., Pan, L., Moens, C. B., Ingham, P. W., Ramesh, T., & Shaw, P. J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt082 · Cited by 55
Distinct pathways leading to TDP-43-induced cellular dysfunctions
Yamashita, M., Nonaka, T., Hirai, S., Miwa, A., Okado, H., Arai, T., Hosokawa, M., Akiyama, H., & Hasegawa, M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu152 · Cited by 46
Goossens, J., Vanmechelen, E., Trojanowski, J. Q., Lee, V. M. ‐., Broeckhoven, C. V., van der Zee, J., & Engelborghs, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0195-1 · Cited by 43
Li, Z., Lu, Y., Xu, X., & Gao, F. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds420 · Cited by 45
Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN
Zheng, M., Liao, M., Cui, T.-Y., Tian, H., Fan, D., & Wan, Q. (2012) · Journal of Cell Science · doi:10.1242/jcs.095729 · Cited by 42
RNA as the stone guest of protein aggregation
Louka, A., Zacco, E., Temussi, P. A., Tartaglia, G. G., & Pastore, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa822 · Cited by 37
Isolation and characterization of soluble human full‐length TDP‐43 associated with neurodegeneration
Vivoli, M., Nigro, A., Luti, S., Capitini, C., Fani, G., Gonnelli, L., Boscaro, F., & Chiti, F. (2019) · The FASEB Journal · doi:10.1096/fj.201900474r · Cited by 40
RNA binding proteins: a common denominator of neuronal function and dysfunction
Doxakis, E. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-014-1443-7 · Cited by 40
Pelletier, S. W., Gingras, S., Howell, S. R., Vogel, P., & Ihle, J. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1787-12.2012 · Cited by 39
A molecular mechanism realizing sequence-specific recognition of nucleic acids by TDP-43
Furukawa, Y., Suzuki, Y., Fukuoka, M., Nagasawa, K., Nakagome, K., Shimizu, H., Mukaiyama, A., & Akiyama, S. (2016) · Scientific Reports · doi:10.1038/srep20576 · Cited by 45
Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo
Tripathi, V. B., Baskaran, P., Shaw, C. E., & Guthrie, S. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.004 · Cited by 41
TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain
Yan, S., Wang, C.-E., Wei, W., Gaertig, M. A., Lai, L., Li, S., & Li, X. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt662 · Cited by 38
Translational regulation in the brain by TDP-43 phase separation
Gao, J., Wang, L., Ren, X., Dunn, J., Peters, A., Miyagi, M., Fujioka, H., Zhao, F., Askwith, C. C., Liang, J., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202101019 · Cited by 42
Laferrière, F., & Polymenidou, M. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14054 · Cited by 43
Prasad, A., Sivalingam, V., Bharathi, V., Girdhar, A., & Patel, B. K. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.003 · Cited by 36
Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43
Bose, P., Armstrong, G. A. B., & Drapeau, P. (2018) · Journal of Neurophysiology · doi:10.1152/jn.00265.2018 · Cited by 37
Versluys, L., Pereira, P. E., Schuermans, N., Paepe, B. D., Bleecker, J. D., Bogaert, E., & Dermaut, B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.815765 · Cited by 34
Disturb mitochondrial associated proteostasis: Neurodegeneration and imperfect ageing
Jagtap, Y. A., Kumar, P., Kinger, S., Dubey, A. R., Choudhary, A., Gutti, R. K., Singh, S., Jha, H. C., Poluri, K. M., & Mishra, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1146564 · Cited by 36
Takeuchi, T., Maeta, K., Ding, X., Oe, Y., Takeda, A., Inoue, M., Nagano, S., Fujihara, T., Matsuda, S., Ishigaki, S., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.006 · Cited by 34
Lépine, S., Nauleau-Javaudin, A., Deneault, É., Chen, C. X. ‐., Abdian, N., Franco-Flores, A. K., Haghi, G., Castellanos‐Montiel, M. J., Maussion, G., Chaineau, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109166 · Cited by 40
TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
Buratti, E., Romano, M., & Baralle, F. E. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.03.001 · Cited by 32
TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients
Simula, E. R., Arru, G., Zarbo, I. R., Solla, P., & Sechi, L. A. (2021) · Viruses · doi:10.3390/v13112301 · Cited by 33
Verde, E. M., Secco, V., Ghezzi, A., Mandrioli, J., & Carra, S. (2025) · Cells · doi:10.3390/cells14100680 · Cited by 35
Baloh, R. H. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a269b · Cited by 33
Bjork, R. T., Mortimore, N. P., Loganathan, S., & Zarnescu, D. C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.840357 · Cited by 36
Jiang, L., & Ngo, S. T. (2022) · Metabolites · doi:10.3390/metabo12080709 · Cited by 35
Cytoplasmic TDP43 Binds microRNAs: New Disease Targets in Amyotrophic Lateral Sclerosis
Paez-Colasante, X., Figueroa‐Romero, C., Rumora, A. E., Hur, J., Mendelson, F. E., Hayes, J. M., Backus, C., Taubman, G. F., Heinicke, L. A., Walter, N. G., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00117 · Cited by 33
TDP-43—The key to understanding amyotrophic lateral sclerosis
Xu, Z., & Yang, C. (2014) · Rare Diseases · doi:10.4161/21675511.2014.944443 · Cited by 36
Besnard‐Guérin, C. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14762 · Cited by 28
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD
Shenouda, M., Zhang, A. B., Weichert, A., & Robertson, J. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_9 · Cited by 31
TDP-43 safeguards the embryo genome from L1 retrotransposition
Li, T. D., Murano, K., Kitano, T., Guo, Y., Negishi, L., & Siomi, H. (2022) · Science Advances · doi:10.1126/sciadv.abq3806 · Cited by 32
RNA binding proteins in senescence: A potential common linker for age-related diseases?
Varesi, A., Campagnoli, L. I. M., Barbieri, A., Rossi, L., Ricevuti, G., Esposito, C., Chirumbolo, S., Marchesi, N., & Pascale, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101958 · Cited by 29
TDP‐43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong, M. J., & Volkening, K. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08277.x · Cited by 28
Imaizumi, K., Ideno, H., Sato, T., Morimoto, S., & Okano, H. (2022) · eNeuro · doi:10.1523/eneuro.0061-22.2022 · Cited by 27
ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons
Han, J. H., Yu, T.-H., Ryu, H.-H., Jun, M.-H., Ban, B.-K., Jang, D., & Lee, J. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.025 · Cited by 28
TDP-43: A new player on the AD field?
Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28
Cassel, J. A., Blass, B. E., Reitz, A. B., & Pawlyk, A. C. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110382778 · Cited by 27
Chang, J., & Morton, D. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180828 · Cited by 27
Swarup, V., Audet, J., Phaneuf, D., Križ, J., & Julien, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2267-12.2012 · Cited by 26
TDP-43 in the spectrum of MND-FTLD pathologies
Heyburn, L., & Moussa, C. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.001 · Cited by 27
Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
Bräuer, S., Zimyanin, V. L., & Hermann, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1851-y · Cited by 29
Delineating the effect of mutations on the conformational dynamics of N-terminal domain of TDP-43
Kumar, V., Pandey, P., Idrees, D., Prakash, A., & Lynn, A. M. (2019) · Biophysical Chemistry · doi:10.1016/j.bpc.2019.106174 · Cited by 26
Metadata
- Authors
- Sephton, C. F., Good, S. K., Atkin, S., Dewey, C. M., Mayer, P., Herz, J., & Yu, G.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Yu, Gang
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 285
- Issue
- 9
- Pages
- 6826-6834
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2825476
- OpenAlex
- W2069350252
- Cited by
- 370
- References
- 31
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 12 · 2023: 22 · 2022: 30 · 2021: 24 · 2020: 17 · 2019: 23 · 2018: 25 · 2017: 20 · 2016: 17 · 2015: 17 · 2014: 32 · 2013: 30 · 2012: 25
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG023104, R01AG029547, R01AG023104)
- National Heart, Lung, and Blood Institute (R37HL063762)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- TDP-43, TARDBP, embryonic development, gene trap, conditional knockout mice, neural progenitor cells, neuroepithelium, motor neurons, dorsal root ganglia, developmental regulation, neurodegenerative diseases, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, ubiquitin-positive inclusions
- MeSH terms
- Animals, Animals, Newborn, Blastocyst, Central Nervous System, DNA-Binding Proteins, Heterozygote, Homozygote, Neurons, Stem Cells, Tissue Distribution, Gene Expression Regulation, Developmental, Neurodegenerative Diseases, Embryonic Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review